Viking Global Investors LP Bridge Bio Pharma, Inc. Transaction History
Viking Global Investors LP
- $29.6 Billion
- Q4 2024
A detailed history of Viking Global Investors LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 25,120,991 shares of BBIO stock, worth $882 Million. This represents 2.33% of its overall portfolio holdings.
Number of Shares
25,120,991
Previous 25,120,991
-0.0%
Holding current value
$882 Million
Previous $640 Million
7.78%
% of portfolio
2.33%
Previous 2.47%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
320Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$887 Million44.98% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$437 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$217 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$213 Million61.0% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.2B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...